Literature DB >> 268981

Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia.

L W Dow, L Borella, L Sen, R J Aur, S L George, A M Mauer, J V Simone.   

Abstract

Bone marrow lymphoblasts from 109 children admitted with untreated acute lymphoblastic leukemia (ALL) were tested for spontaneous rosette formation with sheep erythrocytes. Twenty-six children (24%) had lymphoblasts that formed rosettes (E+). Of 13 initial clinical characteristics, 8 were significantly associated with E+ lymphoblasts: mediastinal enlargement (86% of patients E+), leukocyte counts over 100 X 10(9)/liter (65% E+), nodes greater than 2 cm in any diameter (65% E+), age over 5 yr (46% E+), hemoglobin over 8 g/dl (44% E+), hepatomegaly greater than 5 cm (38% E+), boys (35% E+), and lymph node enlargement outside of the cervical area (28% E+). Spleen size, initial platelet counts, and periodic acid-Schiff scores did not distinguish E+ from E- patients. Since few patients were black and few presented with central nervous system leukemia, the association of these two characteristics with E+ blasts could not be determined. A hierarchical classification scheme and a linear logistic regression model were used to define the patterns of characteristics associated with E+ lymphoblasts. The initial clinical characteristics and the poorer course of E+ patients suggest that ALL comprises at least two biologically and clinically distinct types. The E+ ALL may result from a leukemic transformation of a non-Hodgkin lymphoma.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 268981

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  Malignant lymphomas--a conceptual understanding of morphologic diversity. A review.

Authors:  R B Mann; E S Jaffe; C W Berard
Journal:  Am J Pathol       Date:  1979-01       Impact factor: 4.307

2.  Long survival in acute myelogenous leukaemia: an international collaborative study.

Authors:  J A Whittaker; P Reizenstein; S T Callender; G G Cornwell; I W Delamore; R P Gale; M Gobbi; P Jacobs; B Lantz; A T Maiolo; J K Rees; E J Van Slyck; H V Van
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-28

3.  Current management of childhood acute lymphocytic leukemia.

Authors:  H Ekert
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

4.  Analysis of the binding of peanut agglutinin (PNA) to leukaemic cells and its relationship to T-cell differentiation.

Authors:  R A Newman; D Delia
Journal:  Immunology       Date:  1983-05       Impact factor: 7.397

Review 5.  Childhood acute lymphocytic leukemia: progress and problems in treatment.

Authors:  W P Bowman
Journal:  Can Med Assoc J       Date:  1981-01-15       Impact factor: 8.262

6.  Multidisciplinary care in pediatric oncology.

Authors:  Mary Ann Cantrell; Kathy Ruble
Journal:  J Multidiscip Healthc       Date:  2011-05-30

Review 7.  Childhood acute lymphoblastic leukaemia: a review.

Authors:  M L Willoughby
Journal:  J R Soc Med       Date:  1982-06       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.